LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation

April Reynolds1, Elizabeth A Doggett1, Steve M Riddle2

  • 1Parkinson's Institute Sunnyvale, CA, USA.

Insights

Parkinson's disease (PD) genetics reveal that Leucine-Rich Repeat protein Kinase 2 (LRRK2) mutations enhance kinase activity and alter cellular phosphorylation. Analyzing LRRK2 phosphosites offers distinct measures of its biological activity.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Missense mutations in the Leucine-Rich Repeat protein Kinase 2 (LRRK2) gene are a primary genetic risk factor for Parkinson's disease (PD).
  • LRRK2, a serine/threonine kinase, is implicated in neuronal toxicity, but its precise pathogenic mechanisms remain unclear.
  • LRRK2 exhibits autophosphorylation and is constitutively phosphorylated at specific cellular sites (Ser910, Ser935, Ser955, Ser973), potentially regulated by upstream kinases.

Purpose of the Study:

  • To investigate the phosphoregulation of LRRK2 at key sites in response to disease-associated mutations and specific inhibitors.
  • To analyze the impact of mutations in the Roc-COR domains and alanine substitutions of phosphosites on LRRK2 kinase activity.
  • To elucidate the distinct roles of Ser1292 and cellular site phosphorylation in measuring LRRK2 activity.

Main Methods:

  • Analysis of disease-associated LRRK2 mutations (e.g., Arg1441Cys, Gly2019Ser) and alanine substitutions at phosphosites (Ser910, 935, 955, 973).
  • Assessment of LRRK2 autophosphorylation at Ser1292 and cellular site phosphorylation under various conditions, including LRRK2 inhibition.
  • Investigation of the effects of increased cAMP levels and specific phosphatases (Calyculin A, Okadaic acid) on LRRK2 phosphorylation.

Main Results:

  • Roc-COR domain mutants (e.g., Arg1441Cys, Tyr1699Cys) enhance LRRK2 kinase activity and induce dephosphorylation of cellular sites.
  • While individual cellular site mutations had no effect, Ser910/935/955/973Ala mutations showed a trend toward increased LRRK2 kinase activity.
  • LRRK2 kinase inhibition dephosphorylated Ser1292, while cellular sites were dephosphorylated by Calyculin A-sensitive phosphatases.

Conclusions:

  • Specific LRRK2 mutations can modulate its kinase activity and affect cellular phosphorylation patterns.
  • Phosphorylation at Ser1292 and the cellular sites (Ser910/935/955/973) represent distinct and valuable indicators of LRRK2 activity.
  • Comparative analysis of these phosphorylation sites provides a comprehensive understanding of LRRK2's biological function in vitro and in vivo.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.5K
Cell Signaling in Plants01:25

Cell Signaling in Plants

Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
4.5K